Dr Tom York, Richmond Pharmacology’s Associate Medical Director, recently wrote for Pharmaceutical Market Europe where he outlined how telemonitoring can support the patient to manage chronic diseases through a flexible treatment environment, as well as increase productivity in the pharmaceutical industry.

Richmond Pharmacology always searches for the most innovative processes to improve clinical trials and the patients’ experiences and treatments. Clinicians can review data provided by patients in real time, allowing them to quickly intervene to adjust therapy. For example, remote monitoring can help speed diagnosis and improve treatment outcomes in trials for ATTR cardiac amyloidosis (ATTR-CM). Furthermore, telemonitoring has many benefits, including savings to clinical trial management and providing the path for the development of new models of clinical trials, such as decentralised clinical trials.

CROs, such as Richmond Pharmacology, are transforming the way trials are delivered and data is analysed. Telemonitoring can be utilised in advancing models of clinical trials, all while saving substantial time and resources for sponsors, facilitating faster progress to phase III studies, and ensuring, over time, that approved medicines are reaching the patients who need them. However, Telemonitoring does not just represent a change in process, it requires different skills, new ways of working, and training programmes that keep pharmaceutical doctors aligned with the latest practices and trends. 

To read the full article, click here.

Latest news

How Does Social Time Contribute to a Positive Workplace Culture?

March 13, 2023
Read the blog by Richmond Pharmacology’s Chair of the Social Committee and Head of Marketing, Elizabeth Romano about how being social improves organisational culture and embeds the core values.
Read more

Employee Well-Being: A Commitment that Defines Richmond

October 2, 2023
Dr. Junko Ono, the Occupational Support Manager at Richmond Pharmacology provides her insights on fostering a positive work environment.
Read more


ISA Symposium 2024

29-30 May 2024 
We will be attending the XIX International Symposium on Amyloidosis, taking place in Rochester, Minesota
View event